Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer

Peptides

Volumn 31, Issue 11, 2010, Pages 2035-2045

  Valdehita, Ana ^a   Bajo, Ana M ^a   Fernández Martínez, Ana B ^a   Arenas, M Isabel ^a   Vacas, Eva ^a   Valenzuela, Pedro ^b   Ruíz Villaespesa, Antonio ^b   Prieto, Juan C ^a   Carmena, María J ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

cAMP; Human breast cancer; Nuclear VPAC receptors; VIP receptors

Indexed keywords

CALCITRIOL RECEPTOR; ESTROGEN; LIGAND; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; CYCLIC AMP; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; VASOACTIVE INTESTINAL PEPTIDE;

EID: 77957829687     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.07.024     Document Type: Article

References (57)

1. G. Bkaily, S. Choufani, G. Hassan, N. El-Bizri, D. Jacques, and P. D'Orleans-Juste Presence of functional endothelin 1 receptors in nuclear membrane of human aortic vascular smooth muscle cells Journal of Cardiovascular Pharmacology 36 2000 414 417
2. + exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells Canadian Journal of Physiology and Pharmacology 84 2006 431 441
3. B. Boivin, C. Lavoie, G. Vaniotis, A. Baragli, L.R. Villeneuve, and N. Either Functional β-adrenergic receptor signaling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes Cardiovascular Research 71 2006 69 78
4. K. Buchner Protein kinase C in the transduction of signals toward and within the cell nucleus European Journal of Biochemistry 228 1995 211 221
5. J.T. Chang, I.H. Chen, C.T. Liao, H.M. Wang, Y.M. Hsu, and K.F. Hung A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients Clinical Biochemistry 35 2002 591 596
6. M. Cheng, T.G. Boulton, and M.H. Cobb ERK3 is a constitutively nuclear protein kinase Journal of Biological Chemistry 271 1996 8951 8958
7. B. Collado, I. Gutiérrez-Cañas, N. Rodríguez-Henche, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells Regulatory Peptides 119 2004 69 75
8. 2+ signalling. Implications in angiogenesis and neuroendocrine differentiation Biochimica et Biophysica Acta 1744 2005 224 233
9. M. Eriksson, B. Lindh, K. Uvnäs-Moberg, and T. Hökfelt Distribution and origin of peptide-containing nerve fibres in the rat and human mammary gland Neuroscience 70 1996 227 245
10. Q. Feng, Y. Zhang, Y. Li, Z. Liu, J. Zuo, and F. Fang Two domains are critical for the nuclear localization of soluble adenylyl cyclase Biochimie 88 2006 319 328
11. M.B. Fernández-Martínez, A.M. Bajo, M. Sánchez- Chapado, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells Prostate 69 2009 774 786
12. Z. Freyberg, D. Sweeney, A. Siddhanta, S. Bourgoin, M. Frohman, and D. Shields Intracellular localization of phospholipase D1 in mammalian cells Molecular Biology of the Cell 12 2001 943 955
13. M.O. García-Fernández, B. Collado, G. Bodega, J. Cortés, A. Ruíz-Villaespesa, and M.J. Carmena Pituitary adenylate ciclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue Gynecological Endocrinology 20 2005 327 333
14. A.G. Gilman A protein binding assay for adenosine 3′:5′- cyclic monophosphate Proceedings of the National Academy of Sciences of USA 67 1970 305 311
15. F. Gobeil Jr., S.G. Bernier, A. Vazquez-Tello, S. Brault, M.H. Beauchamp, and C. Quiniou Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1 Journal of Biological Chemistry 278 2003 38875 38883
16. F. Gobeil Jr., I. Dummont, A.M. Marrache, A. Vazquez-Tello, S.G. Bernier, and D. Abran Regulation of eNS expression in brain endothelial cells by perinuclear EP(3) receptors Circulation Research 90 2002 682 689
17. F. Gobeil Jr., A. Fortier, T. Zhu, M. Bossolasco, M. Leduc, and M. Grandbois G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm Canadian Journal of Physiology and Pharmacology 84 2006 287 297
18. F. Gobeil Jr., A. Vazquez-Tello, A.M. Marrache, M. Bhattacharya, D. Checchin, and G. Bkaily Nuclear prostaglandin signaling system: biogenesis and activation via heptahelical receptors Canadian Journal of Physiology and Pharmacology 81 2003 196 204
19. F. Gobeil Jr., T. Zhu, S. Brault, A. Geha, A. Vazquez-Tello, and A. Fortier Nitric oxide signaling via nuclearized e-NOS in the expression of immediate early genes i-NOs and mPGES-1 Journal of Biological Chemistry 281 2006 16058 16067
20. E.J. Goetzl Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands FASEB Journal 21 2007 638 642
21. E.J. Goetzl Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes Regulatory Peptides 137 2006 75 78
22. D.A. Gomes, M.F. Leite, A.M. Bennett, and M.H. Nathanson Calcium signaling in the nucleus Canadian Journal of Physiology and Pharmacology 84 2006 325 332
23. I. Gutierrez-Cañas, M.G. Juarranz, B. Collado, N. Rodríguez-Henche, A. Chiloeches, and J.C. Prieto Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K Prostate 63 2005 44 55
24. F.J. Iborra, D.A. Jackson, and P.R. Cook Coupled transcription and translation within nuclei of mammalian cells Science 293 2001 1139 1142
25. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NFκB activity Annual Review of Immunology 18 2000 621 663
26. C.G. Kim, D. Park, and S.G. Rhee The role of carboxyl-terminal basic amino acids in Gqα-dependent activation, particulate association, and nuclear localization of phospholipase C-β1 Journal of Biological Chemistry 271 1996 21187 21192
27. M. Laburthe, A. Couvineau, and V. Tan Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology Peptides 28 2007 1631 1639
28. M. Laburthe, and A. Couvineau Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP Regulatory Peptides 108 2002 165 173
29. D.K. Lee, A.J. Lana, R. Cheng, T. Nguyen, X.D. Ji, and F. Gobeil Jr. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors Journal of Biological Chemistry 279 2004 7901 7908
30. G.J. Lind, and H.D. Cavanagh Identification and subcellular distribution of muscarinic acetylcholine receptor-related proteins in rabbit corneal and Chinese hamsters ovarian cells Investigative Ophthalmological and Visual Sciences 36 1995 1492 1507
31. B. Madsen, B. Georg, M.W. Madsen, and J. Fahrenkrug Estradiol down regulates expression of vasoactive intestinal polypeptides receptor type-1 in breast cancer cell lines Molecular and Cellular Endocrinology 172 2001 203 211
32. A.N. Malviya, and C. Klein Mechanism regulating nuclear calcium signaling Canadian Journal of Physiology and Pharmacology 84 2006 403 422
33. A.M. Marrache, F. Gobeil Jr., S.G. Bernier, J. Stankova, M. Rola-Pleszczynski, and S. Choufani Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor Journal of Immunology 169 2002 6474 6481
34. T.W. Moody, G. Czerwinski, N.Y. Tarasova, and C.J. Michejda VIP-ellipticine derivatives inhibit the growth of breast cancer cells Life Sciences 71 2002 1005 1014
35. T.W. Moody, and I. Gozes Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer Current Pharmacological Designs 13 2007 1099 1104
36. T.W. Moody, J.M. Hill, and R.T. Jensen VIP as a trophic factor in the CNS and cancer cells Peptides 24 2003 163 177
37. T.W. Moody, R.T. Jensen, M. Fridkin, and I. Gozes (N-stearyl, norleucine17)VIP hybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist Journal of Molecular Neurosciences 18 2002 29 35
38. T.W. Moody, and R.T. Jensen Breast cancer VPAC1 receptors Annals of the New York Academy of Sciences 1070 2006 436 439
39. P.J. Munson, and D. Rodbard LIGAND: a versatile approach for characterization of ligand-binding systems Analytical Biochemistry 107 1980 220 239
40. L.M. Neri, P. Borgatti, S. Capitani, and A.M. Martelli The nuclear phosphoinisitide 3-kinase/AKT pathways: a new second messenger system Biochimica et Biophysica Acta 1584 2002 73 80
41. C.K. Nielsen, J.I. Campbell, J.F. Ohd, M. Mörgelin, K. Riesbeck, and G. Landberg A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells Cancer Research 65 2005 732 742
42. 2+ changes in heterologous cell types and neurons Journal of Biological Chemistry 278 2003 28210 28219
43. M.B. Omary, and M.F. Kagnoff Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line Science 238 1987 1578 1581
44. J.C. Reubi Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging Journal of Nuclear Medicine 36 1995 1825 1835
45. S. Sachdev, A. Hoffmann, and M. Hannink Nuclear localization of IκB alpha is mediated by the second ankyrin repeat: the IκB α ankyrin repeats define a novel class of cis-acting nuclear import sequences Molecular and Cellular Biology 18 1998 2524 2534
46. M. Sastri, D.M. Barraclough, P.T. Carmichael, and S.S. Taylor A-kinase-interacting protein localizes protein kinase A in the nucleus Proceedings of the National Academy of Sciences of USA 102 2005 349 354
47. A.R. Schievella, M.K. Regier, W.L. Smith, and L.L. Lin Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum Journal of Biological Chemistry 270 1995 30749 30754
48. S. Sotomayor, M.J. Carmena, A.V. Schally, J.L. Varga, M. Sánchez-Chapado, and J.C. Prieto Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone International Journal of Oncology 31 2007 1223 1230
49. J.P. Spano, F. André, L. Morat, L. Sabatier, B. Besse, and C. Combadiere Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome Annals of Oncology 15 2004 613 617
50. A. Valdehita, A.M. Bajo, A.V. Schally, J.L. Varga, M.J. Carmena, and J.C. Prieto Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells Molecular and Cellular Endocrinology 302 2009 41 48
51. A. Valdehita, M.J. Carmena, B. Collado, J.C. Prieto, and A.M. Bajo Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells Regulatory Peptides 144 2007 101 108
52. 2 receptor is essential for the receptor structure Peptides 22 2001 1363 1370
53. J.A. Waschek, M.L. Richards, and D.T. Bravo Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines Cancer Letters 92 1995 143 149
54. F.S. Willard, and M.F. Crouch Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins Immunology and Cell Biology 78 2000 387 394
55. S. Yamamoto, K. Kawamura, and T.N. James Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry Microscopy Research and Technique 40 1998 479 487
56. K. Zhang, M.R. Aruva, N. Shanthly, C.A. Cardi, C.A. Patel, and S. Rattan Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation Regulatory Peptides 144 2007 91 100
57. H. Zia, T. Hida, S. Jakowlew, M. Birrer, Y. Gozes, and J.C. Reubi Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist Cancer Research 56 1996 3486 3489